Affymax Shares Fall Amid Plan to Halt Expansion of Pilot, Pare Loss as Analysts Defend

By: Benzinga
Shares of Affymax (NASDAQ: AFFY ) gapped more than 30 percent lower at Thursday morning's open following an 8-K which disclosed the company will halt the expansion of its Omontys pilot. The company suggested continuing use of Omontys for the management of anemia. The stock began bouncing shortly after the
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.